ID: ALA106949

Max Phase: Preclinical

Molecular Formula: C25H48N2O4

Molecular Weight: 440.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)NC[C@H]1C[N+](C)(C)C[C@@H](CC(=O)[O-])O1

Standard InChI:  InChI=1S/C25H48N2O4/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24(28)26-19-23-21-27(2,3)20-22(31-23)18-25(29)30/h22-23H,4-21H2,1-3H3,(H-,26,28,29,30)/t22-,23+/m1/s1

Standard InChI Key:  UTNAVGQVJRZGPJ-PKTZIBPZSA-N

Associated Targets(Human)

Carnitine palmitoyltransferase 2 510 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Carnitine palmitoyltransferase 2 485 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carnitine palmitoyltransferase 1A 532 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 440.67Molecular Weight (Monoisotopic): 440.3614AlogP: 3.57#Rotatable Bonds: 18
Polar Surface Area: 78.46Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.04CX Basic pKa: CX LogP: 1.15CX LogD: 1.92
Aromatic Rings: 0Heavy Atoms: 31QED Weighted: 0.26Np Likeness Score: 0.09

References

1. Savle PS, Pande SV, Lee TS, Gandour RD..  (1999)  Stereoisomeric acylamidomorpholinium carnitine analogues: selective inhibitors of carnitine palmitoyltransferase I and II.,  (21): [PMID:10560732] [10.1016/s0960-894x(99)00543-0]

Source